Journal of Reproductive Immunology ( IF 2.9 ) Pub Date : 2021-03-30 , DOI: 10.1016/j.jri.2021.103317 Mohammad Ali Zolfaghari 1 , Roza Motavalli 2 , Mohammad Sadegh Soltani-Zangbar 3 , Forough Parhizkar 3 , Shahla Danaii 4 , Leili Aghebati-Maleki 5 , Mohammad Noori 6 , Sanam Dolati 7 , Majid Ahmadi 3 , Hossein Samadi Kafil 8 , Farhad Jadidi-Niaragh 9 , Javad Ahmadian Heris 10 , Ata Mahmoodpoor 11 , Mohammad Saeid Hejazi 2 , Mehdi Yousefi 12
Background
Alongside many complications in understanding the etiology of Preeclampsia (PE), several determinants, such as the imbalanced proportion of anti-angiogenic/proangiogenic T-cell subsets, especially CD4+ (Th17/Treg), as well as alterations in the expression profile of related cytokines, miRNAs, and transcription factors might have been implicated in PE pathogenesis.
Material and method
After sample collection and preparation, CD4+ cells were isolated from PE and non-PE pregnant woman and were cultured. Furthermore, analysis such as flow cytometry, real-time PCR, western blotting, and ELISA were performed to assess determinants related to PE manifestation, including sFlt-1, sEng, STAT-3, RORγt, SMAD-7, Foxp3, IL-17, IL-22, Ets-1, and miRNA-326.
Results
Our results showed that the miRNA-326 expression level increased in CD4+ Cells and Th17 in PE patients which downregulated Ets-1 expression that acts as a negative control for Th17 development. Furthermore, we showed that the number and expression level of Th17 s and transcription factor RORγt escalated, respectively. While Treg and its related transcription factor (Foxp3) demonstrated a decrease. Flow cytometry analysis illustrated that the Th17/Treg ratio increased in PE. Additionally, we demonstrated that expression and concentration levels of cytokines (IL-17 and IL22) and anti-angiogenic molecules (sEng and sFlt-1) soared in isolated CD4+ cells from PE patients, which could be correlated with PE pathogenicity.
Conclusion
In conclusion, we comprehensively evaluated immunological factors and molecules involved in PE manifestation. Interestingly, the CD4+ T-cell subset could be an extra source of antiangiogenic factors for the maintenance of this hypertension disorder.
中文翻译:
一种解决先兆子痫难题的新方法;CD4+ 淋巴细胞中的 MicroRNA-326 可能是一个潜在的嫌疑人
背景
除了在理解先兆子痫 (PE) 的病因方面存在许多并发症外,还有几个决定因素,例如抗血管生成/促血管生成 T 细胞亚群的比例不平衡,尤其是 CD4 + (Th17/Treg),以及相关细胞因子、miRNA 和转录因子可能与 PE 发病机制有关。
材料和方法
样品采集和制备后,从PE和非PE孕妇中分离CD4 +细胞并进行培养。此外,还进行了流式细胞术、实时 PCR、蛋白质印迹和 ELISA 等分析以评估与 PE 表现相关的决定因素,包括 sFlt-1、sEng、STAT-3、RORγt、SMAD-7、Foxp3、IL-17 、IL-22、Ets-1 和miRNA-326。
结果
我们的结果表明,在 PE 患者的CD4 +细胞和 Th17 中miRNA-326表达水平增加,这会下调作为 Th17 发展的阴性对照的Ets-1表达。此外,我们发现 Th17 s 和转录因子ROR γ t的数量和表达水平分别升高。而 Treg 及其相关转录因子 (Foxp3) 表现出下降。流式细胞术分析表明,PE 中 Th17/Treg 比值增加。此外,我们证明细胞因子(IL-17 和 IL22)和抗血管生成分子(sEng 和 sFlt-1)的表达和浓度水平在分离的 CD4 + PE 患者的细胞,这可能与 PE 的致病性有关。
结论
总之,我们综合评估了参与 PE 表现的免疫因素和分子。有趣的是,CD4 + T 细胞亚群可能是维持这种高血压疾病的抗血管生成因子的额外来源。